• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Elanco Animal Health (ELAN) Tests Its Undervalued View After Fresh Loss And Revenue Data

    Simply Wall St·11/06/2026 07:30:04
    Listen to the news

    Elanco Animal Health (ELAN) is in focus after fresh performance data showed annual revenue of US$5.02b and a reported net loss of US$199m. Investors are weighing these figures against recent share price gains.

    Over the past year, Elanco Animal Health has seen a 10.04% total shareholder return, while the 90 day share price return of 7.05% and 30 day gain of 5.34% suggest momentum has been building despite a recent 1 day pullback of 6.44% from the latest close at US$23.68.

    Compare Elanco Animal Health's recent momentum and loss-making profile with other hand-picked businesses on our 21 high quality undiscovered gems, which pair strong fundamentals with less market attention.

    Elanco Animal Health has a broad product footprint and fresh momentum in the share price, yet the business is still reporting a loss. So are investors paying a fair price for that mix today?

    Most Popular Narrative: 22% Undervalued

    Against the last close at $23.68, the most followed narrative for Elanco Animal Health points to a fair value of $30.23 based on a 7.24% discount rate and detailed assumptions around future earnings, margins and cash flows.

    The efficiency and mix improvement theme has advanced through the Elanco Ascend productivity program and higher margin biologics, with an 80 basis point gross margin improvement to 58.1% in Q2 2026 and a target of US$200 million to US$250 million of EBITDA savings by 2030. The completed mAb capacity expansion in Kansas gives additional room for margin and earnings expansion as higher margin products scale.

    See why 15 investors see Elanco Animal Health as 22% undervalued.

    Result: Fair Value of $30.23 (UNDERVALUED)

    Still, Elanco Animal Health carries real pressure points, including foreign exchange drag on international revenue and the risk that pricing or farm animal demand softens.

    Find out about the key risks to this Elanco Animal Health narrative.

    Next Steps

    Mixed signals on Elanco Animal Health so far. If you want to move quickly and anchor your own view in the numbers, start by weighing the 4 key rewards

    Looking for more investment ideas beyond Elanco Animal Health?

    If Elanco Animal Health has sharpened your focus, do not stop here. Put that momentum to work by lining up a few more opportunities worth your attention.